» Authors » Christopher C Moore

Christopher C Moore

Explore the profile of Christopher C Moore including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 101
Citations 1016
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gashame D, Boateng K, Twagirumukiza J, de Dieu Mahoro J, Moore C, Twagirumugabe T
PLOS Glob Public Health . 2024 Dec; 4(12):e0003695. PMID: 39652578
There are few data regarding clinical outcomes from COVD-19 from low-income countries (LICs) including Rwanda. Accordingly, we aimed to determine 1) outcomes of patients admitted to hospital with COVID-19 in...
2.
Jacinta Ojia A, Lyon S, Birungi J, Owomugisha C, Muhindo R, Sekitene S, et al.
Open Forum Infect Dis . 2024 Nov; 11(11):ofae634. PMID: 39553287
Background: Little is known about outcomes from cancer chemotherapy--associated infections in sub-Saharan Africa. Accordingly, among patients with cancer admitted with postchemotherapy infection in Mbarara, Uganda, we aimed to determine (1)...
3.
Null M, Conaway M, Hazard R, Edwards L, Taseera K, Muhindo R, et al.
PLOS Glob Public Health . 2024 Oct; 4(10):e0003797. PMID: 39436893
Sepsis is the leading cause of global death with the highest burden found in sub-Saharan Africa (sSA). The Universal Vital Assessment (UVA) score is a validated resource-appropriate clinical tool to...
4.
Lal S, Luangraj M, Keddie S, Ashley E, Baerenbold O, Bassat Q, et al.
EClinicalMedicine . 2024 Oct; 77:102856. PMID: 39416389
Background: Clinical severity scores can identify patients at risk of severe disease and death, and improve patient management. The modified early warning score (MEWS), the quick Sequential (Sepsis-Related) Organ Failure...
5.
Cuthbertson C, Evenson K, Wen F, Moore C, Howard A, Di C, et al.
Prev Med . 2024 Jul; 186:108070. PMID: 39029743
Objective: Accumulating more steps/day is associated with a lower risk of cancer mortality and composite cancer outcomes. However, less is known about the relationship of steps/day with the risk of...
6.
Gwaikolo C, Bodo B, Nabawanuka D, Mukiibi M, Seremba E, Muyinda P, et al.
Infect Prev Pract . 2024 Jun; 6(2):100355. PMID: 38854705
Background: In sub-Saharan Africa, the provision of infection prevention and control (IPC) measures are often limited by resource constraints. Aim: To determine the association of supportive supervision activities with the...
7.
Brown N, Da Silva C, Webb C, Matias D, Dias B, Cancio B, et al.
Antimicrob Agents Chemother . 2024 May; 68(7):e0034624. PMID: 38771031
While the malaria parasite continues to cause severe disease globally, Mozambique is disproportionally represented in malaria case totals. Acquisition of copy number variations (CNVs) in the parasite genome contributes to...
8.
Hamaya R, Shiroma Jr E, Moore C, Buring J, Evenson K, Lee I
JAMA Intern Med . 2024 May; 184(7):718-725. PMID: 38767892
Importance: Current US physical activity (PA) guidelines prescribe moderate to vigorous PA (MVPA) time of at least 150 minutes per week for health. An analogous step-based recommendation has not been...
9.
Schilsky S, Howard A, Moore C, Cuthbertson C, Parada Jr H, Lee I, et al.
PLoS One . 2024 Apr; 19(4):e0301233. PMID: 38573893
Background: Describing correlates of physical activity (PA) and sedentary behavior (SB) among postmenopausal cancer survivors can help identify risk profiles and can be used to support development of targeted interventions...
10.
Evenson K, Wen F, Moore C, LaMonte M, Lee I, LaCroix A, et al.
J Meas Phys Behav . 2023 Dec; 6(2):156-161. PMID: 38037607
Purpose: The purpose of this study was to develop 60-second epoch accelerometer intensity cutpoints for vertical axis count and vector magnitude (VM) output from hip-worn tri-axial accelerometers among women 60-91...